- Home
- / Nutraceutical International
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nutraceutical International financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$233 M
FY, 2016
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|
| Revenue | 188.1M | 200.4M | 208.4M | 214.5M | 216.5M | 233.0M |
| Revenue growth, % | 2.9% | 0.9% | 7.6% | |||
| Cost of goods sold | 92.9M | 100.4M | 105.5M | 108.2M | 110.3M | 114.9M |
| Gross profit | 95.2M | 100.0M | 102.9M | 106.3M | 106.2M | 118.0M |
| Gross profit margin, % | 50.6% | 49.9% | 49.4% | 49.6% | 49.1% | 50.7% |
| General and administrative expense | 68.2M | 71.4M | 72.4M | 76.9M | 77.3M | 84.9M |
| Operating expense total | 69.9M | 74.3M | 74.7M | 79.8M | 81.9M | 88.9M |
| Depreciation and amortization | 1.7M | 2.2M | 2.7M | 2.9M | 3.9M | |
| EBIT | 25.3M | 25.7M | 28.1M | 26.5M | 24.3M | 29.2M |
| EBIT margin, % | 13.5% | 12.8% | 13.5% | 12.4% | 11.2% | 12.5% |
| Interest expense | 1.1M | 1.5M | 1.4M | 1.4M | 1.1M | 1.3M |
| Pre tax profit | 24.2M | 24.2M | 26.8M | 25.1M | 23.2M | 27.9M |
| Income tax expense | 8.5M | 8.4M | 9.8M | 9.2M | 8.0M | 9.3M |
| Net Income | 15.7M | 15.8M | 17.0M | 15.9M | 15.3M | 18.7M |